• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    FDA Approves D3 Bio INDs for D3S-003 Phase 1, Elisrasib-D3S-002

    PR NEWSWIRE

    D3 Bio Secures $108M Series B for Global Clinical Trials Program

    PR NEWSWIRE

    D3 Bio Gets FDA BTD & ODD Designation for D3S-001 in Cancers

    PR NEWSWIRE

    D3 Bio Announces Nature Medicine Publication & Present at AACR 2025

    BUSINESSWIRE

    D3 Bio’s D3S-001 Shows Potent KRAS Depletion in Pre-Clinical Studies

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.